Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Kidney Int. 2017 Aug 31;93(1):252–259. doi: 10.1016/j.kint.2017.06.028

Table 2. Adjusted Hazard Ratios for Incident Chronic Kidney Disease by Quartile of Plasma Galectin-3.

Model Quartile of Plasma Level of Galectin-3 (Range, ng/mL) P-value

Quartile 1 (4.4-12.0) Quartile 2 (12.1-14.1) Quartile 3 (14.2-16.7) Quartile 4 (16.8-91.6)
1a 1 [Ref] 1.25 (1.09-1.44) 1.53 (1.32-1.77) 2.22 (1.89-2.60) <0.001
2b 1 [Ref] 1.17 (1.01-1.34) 1.35 (1.16-1.56) 1.84 (1.57-2.17) <0.001
3c 1 [Ref] 1.17 (1.01-1.34) 1.34 (1.16-1.55) 1.81 (1.54-2.13) <0.001
4d 1 [Ref] 1.15 (1.00-1.32) 1.31 (1.13-1.51) 1.75 (1.49-2.06) <0.001
a

Model 1: adjusted for age, sex, race-center, education level, physical activity, smoking status, body mass index, systolic blood pressure, anti-hypertensive medication use, history of cardiovascular disease, diabetes status, fasting blood glucose, rs4644

b

Model 2: Model 1 + estimated glomerular filtration rate-creatinine

c

Model 3: Model 2 + urine albumin-to-creatinine ratio

d

Model 4: Model 3 + troponin T, N-terminal pro B-type natriuretic peptide